UNSPSC 85502116: Supplement left subclavian artery with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left subclavian artery with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03U43KZ

UNSPSC 85502116 Supplement left subclavian artery with nonautologous tissue substitute, percutaneous approach is a Commodity code that describes a specific surgical procedure for vascular repair. However, recent state and local procurement activity under this code does not align with the nominal scope — no recent solicitations target surgical implants or vascular intervention materials or services. Instead, the opportunities posted under this code reflect a mismatch between taxonomy and actual procurement need. The six most recent postings cover independent medical evaluation services for disability pension determinations, surgical benefit carve-out programs for city employees, occupational medical surveillance for transportation workers, emergency and specialty healthcare for detained youth, pharmacy benefit management administration, and temporary health professional staffing across ancillary clinical specialties. None of these solicitations involve subclavian artery repair, vascular prosthetics, or related surgical supplies or implants.

The issuing bodies span state departments, county health systems, city retirement offices, and regional transit authorities across Arizona, California, Florida, and Washington. Without active procurement targeting the code's stated scope — vascular surgical implants or related procedural materials — the code shows little relevant activity for firms positioned to supply left subclavian artery prosthetics or related surgical devices. Vendors in that space should verify classification before pursuing opportunities posted under this code, as the current market signal reflects administrative or clinical service procurement rather than durable medical equipment or implantable devices.